NU 578 UNIT 5 COMPREHENSIVE EXAM – QUESTIONS AND ANSWERS |
VERIFIED AND WELL DETAILED ANSWERS | PLUS RATIONALES |
GUARANTEED PASS | LATEST EXAM UPDATE
*Core Domains*
*Pathopharmacology*
*Advanced Health Assessment*
*Evidence-Based Practice*
*Clinical Decision Making*
*Pharmacotherapeutic Agents*
*Diagnostic Reasoning*
*Health Promotion*
*Patient Safety and Ethics*
*Introduction*
The NU 578 Unit 5 Comprehensive Exam is designed to evaluate advanced
clinical competence and theoretical knowledge essential for professional practice.
This assessment focuses on the integration of complex physiological concepts,
pharmacological interventions, and holistic patient management. By utilizing a
diverse range of multiple-choice and scenario-based questions, the exam
challenges candidates to apply critical thinking and diagnostic reasoning to real-
world clinical situations. The primary goal is to ensure that learners can
,demonstrate proficiency in decision-making and regulatory compliance while
maintaining high ethical standards. This comprehensive tool serves as a
benchmark for readiness in providing safe, evidence-based care in various
healthcare environments.
1. A patient presents with chronic obstructive pulmonary disease (COPD)
exacerbation. Which physiological change is most characteristic of this
condition during an acute episode?
A. Decreased residual volume
B. Increased elastic recoil
C. Air trapping and hyperinflation
D. Increased forced expiratory volume in one second
🟢 C. Air trapping and hyperinflation
🔴 Explanation: In COPD, airflow obstruction leads to air becoming trapped in the
lungs at the end of exhalation, which causes the lungs to hyperinflate over time.
2. A clinician is prescribing a loop diuretic for a patient with congestive heart
failure. Which electrolyte imbalance should be monitored most closely?
A. Hyperkalemia
B. Hypokalemia
,C. Hypernatremia
D. Hypercalcemia
🟢 B. Hypokalemia
🔴 Explanation: Loop diuretics inhibit the sodium-potassium-chloride
cotransporter in the thick ascending limb of the loop of Henle, leading to increased
excretion of potassium.
3. Which regulatory body is primarily responsible for overseeing the safety and
efficacy of new pharmacological agents before they are marketed?
A. Centers for Disease Control and Prevention (CDC)
B. Food and Drug Administration (FDA)
C. Occupational Safety and Health Administration (OSHA)
D. Centers for Medicare & Medicaid Services (CMS)
🟢 B. Food and Drug Administration (FDA)
🔴 Explanation: The FDA is the federal agency in the United States responsible
for the regulation and supervision of food safety, tobacco products, and
pharmaceutical drugs.
4. When evaluating a 45-year-old male with a history of hypertension, the
provider notes a loud S4 gallop on auscultation. What does this finding
typically indicate?
, A. Normal finding in athletes
B. Mitral valve prolapse
C. Ventricular hypertrophy and stiffened ventricle
D. Fluid volume overload in the atria
🟢 C. Ventricular hypertrophy and stiffened ventricle
🔴 Explanation: An S4 heart sound, or atrial gallop, occurs just before S1 and is
associated with atrial contraction into a non-compliant, stiffened ventricle, often
due to long-standing hypertension.
5. A patient is diagnosed with Type 1 Diabetes Mellitus. Which mechanism best
describes the underlying pathophysiology of this disease?
A. Insulin resistance in peripheral tissues
B. Excessive glucagon production by alpha cells
C. Autoimmune destruction of pancreatic beta cells
D. Obesity-induced metabolic syndrome
🟢 C. Autoimmune destruction of pancreatic beta cells
🔴 Explanation: Type 1 Diabetes is characterized by an absolute insulin deficiency
resulting from the immune system attacking and destroying the insulin-producing
beta cells in the pancreas.
VERIFIED AND WELL DETAILED ANSWERS | PLUS RATIONALES |
GUARANTEED PASS | LATEST EXAM UPDATE
*Core Domains*
*Pathopharmacology*
*Advanced Health Assessment*
*Evidence-Based Practice*
*Clinical Decision Making*
*Pharmacotherapeutic Agents*
*Diagnostic Reasoning*
*Health Promotion*
*Patient Safety and Ethics*
*Introduction*
The NU 578 Unit 5 Comprehensive Exam is designed to evaluate advanced
clinical competence and theoretical knowledge essential for professional practice.
This assessment focuses on the integration of complex physiological concepts,
pharmacological interventions, and holistic patient management. By utilizing a
diverse range of multiple-choice and scenario-based questions, the exam
challenges candidates to apply critical thinking and diagnostic reasoning to real-
world clinical situations. The primary goal is to ensure that learners can
,demonstrate proficiency in decision-making and regulatory compliance while
maintaining high ethical standards. This comprehensive tool serves as a
benchmark for readiness in providing safe, evidence-based care in various
healthcare environments.
1. A patient presents with chronic obstructive pulmonary disease (COPD)
exacerbation. Which physiological change is most characteristic of this
condition during an acute episode?
A. Decreased residual volume
B. Increased elastic recoil
C. Air trapping and hyperinflation
D. Increased forced expiratory volume in one second
🟢 C. Air trapping and hyperinflation
🔴 Explanation: In COPD, airflow obstruction leads to air becoming trapped in the
lungs at the end of exhalation, which causes the lungs to hyperinflate over time.
2. A clinician is prescribing a loop diuretic for a patient with congestive heart
failure. Which electrolyte imbalance should be monitored most closely?
A. Hyperkalemia
B. Hypokalemia
,C. Hypernatremia
D. Hypercalcemia
🟢 B. Hypokalemia
🔴 Explanation: Loop diuretics inhibit the sodium-potassium-chloride
cotransporter in the thick ascending limb of the loop of Henle, leading to increased
excretion of potassium.
3. Which regulatory body is primarily responsible for overseeing the safety and
efficacy of new pharmacological agents before they are marketed?
A. Centers for Disease Control and Prevention (CDC)
B. Food and Drug Administration (FDA)
C. Occupational Safety and Health Administration (OSHA)
D. Centers for Medicare & Medicaid Services (CMS)
🟢 B. Food and Drug Administration (FDA)
🔴 Explanation: The FDA is the federal agency in the United States responsible
for the regulation and supervision of food safety, tobacco products, and
pharmaceutical drugs.
4. When evaluating a 45-year-old male with a history of hypertension, the
provider notes a loud S4 gallop on auscultation. What does this finding
typically indicate?
, A. Normal finding in athletes
B. Mitral valve prolapse
C. Ventricular hypertrophy and stiffened ventricle
D. Fluid volume overload in the atria
🟢 C. Ventricular hypertrophy and stiffened ventricle
🔴 Explanation: An S4 heart sound, or atrial gallop, occurs just before S1 and is
associated with atrial contraction into a non-compliant, stiffened ventricle, often
due to long-standing hypertension.
5. A patient is diagnosed with Type 1 Diabetes Mellitus. Which mechanism best
describes the underlying pathophysiology of this disease?
A. Insulin resistance in peripheral tissues
B. Excessive glucagon production by alpha cells
C. Autoimmune destruction of pancreatic beta cells
D. Obesity-induced metabolic syndrome
🟢 C. Autoimmune destruction of pancreatic beta cells
🔴 Explanation: Type 1 Diabetes is characterized by an absolute insulin deficiency
resulting from the immune system attacking and destroying the insulin-producing
beta cells in the pancreas.
